2026-01-01 2026-05-05 2026-05-05 false 16008940 ASTRIX HEALTH LIMITED 2026-07-03 62090 false iso4217:GBP xbrli:pure 16008940 2025-12-31 16008940 2026-05-05 16008940 2026-01-01 2026-05-05 16008940 2024-10-08 16008940 2025-12-31 16008940 2024-10-09 2025-12-31 16008940 bus:SmallEntities 2026-01-01 2026-05-05 16008940 bus:AuditExempt-NoAccountantsReport 2026-01-01 2026-05-05 16008940 bus:FullAccounts 2026-01-01 2026-05-05 16008940 bus:PrivateLimitedCompanyLtd 2026-01-01 2026-05-05 16008940 core:WithinOneYear 2026-05-05 16008940 core:AfterOneYear 2026-05-05 16008940 core:WithinOneYear 2025-12-31 16008940 core:AfterOneYear 2025-12-31 16008940 core:ShareCapital 2026-05-05 16008940 core:SharePremium 2026-05-05 16008940 core:RevaluationReserve 2026-05-05 16008940 core:OtherReservesSubtotal 2026-05-05 16008940 core:RetainedEarningsAccumulatedLosses 2026-05-05 16008940 core:ShareCapital 2025-12-31 16008940 core:SharePremium 2025-12-31 16008940 core:RevaluationReserve 2025-12-31 16008940 core:OtherReservesSubtotal 2025-12-31 16008940 core:RetainedEarningsAccumulatedLosses 2025-12-31 16008940 core:LandBuildings 2026-05-05 16008940 core:PlantMachinery 2026-05-05 16008940 core:Vehicles 2026-05-05 16008940 core:FurnitureFittings 2026-05-05 16008940 core:OfficeEquipment 2026-05-05 16008940 core:NetGoodwill 2026-05-05 16008940 core:IntangibleAssetsOtherThanGoodwill 2026-05-05 16008940 core:ListedExchangeTraded 2026-05-05 16008940 core:UnlistedNon-exchangeTraded 2026-05-05 16008940 core:LandBuildings 2025-12-31 16008940 core:PlantMachinery 2025-12-31 16008940 core:Vehicles 2025-12-31 16008940 core:FurnitureFittings 2025-12-31 16008940 core:OfficeEquipment 2025-12-31 16008940 core:NetGoodwill 2025-12-31 16008940 core:IntangibleAssetsOtherThanGoodwill 2025-12-31 16008940 core:ListedExchangeTraded 2025-12-31 16008940 core:UnlistedNon-exchangeTraded 2025-12-31 16008940 core:LandBuildings 2026-01-01 2026-05-05 16008940 core:PlantMachinery 2026-01-01 2026-05-05 16008940 core:Vehicles 2026-01-01 2026-05-05 16008940 core:FurnitureFittings 2026-01-01 2026-05-05 16008940 core:OfficeEquipment 2026-01-01 2026-05-05 16008940 core:NetGoodwill 2026-01-01 2026-05-05 16008940 core:IntangibleAssetsOtherThanGoodwill 2026-01-01 2026-05-05 16008940 core:ListedExchangeTraded 2026-01-01 2026-05-05 16008940 core:UnlistedNon-exchangeTraded 2026-01-01 2026-05-05 16008940 core:MoreThanFiveYears 2026-01-01 2026-05-05 16008940 core:Non-currentFinancialInstruments 2026-05-05 16008940 core:Non-currentFinancialInstruments 2025-12-31 16008940 dpl:CostSales 2026-01-01 2026-05-05 16008940 dpl:DistributionCosts 2026-01-01 2026-05-05 16008940 core:LandBuildings 2026-01-01 2026-05-05 16008940 core:PlantMachinery 2026-01-01 2026-05-05 16008940 core:Vehicles 2026-01-01 2026-05-05 16008940 core:FurnitureFittings 2026-01-01 2026-05-05 16008940 core:OfficeEquipment 2026-01-01 2026-05-05 16008940 dpl:AdministrativeExpenses 2026-01-01 2026-05-05 16008940 core:NetGoodwill 2026-01-01 2026-05-05 16008940 core:IntangibleAssetsOtherThanGoodwill 2026-01-01 2026-05-05 16008940 dpl:GroupUndertakings 2026-01-01 2026-05-05 16008940 dpl:ParticipatingInterests 2026-01-01 2026-05-05 16008940 dpl:GroupUndertakings core:ListedExchangeTraded 2026-01-01 2026-05-05 16008940 core:ListedExchangeTraded 2026-01-01 2026-05-05 16008940 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2026-01-01 2026-05-05 16008940 core:UnlistedNon-exchangeTraded 2026-01-01 2026-05-05 16008940 dpl:CostSales 2024-10-09 2025-12-31 16008940 dpl:DistributionCosts 2024-10-09 2025-12-31 16008940 core:LandBuildings 2024-10-09 2025-12-31 16008940 core:PlantMachinery 2024-10-09 2025-12-31 16008940 core:Vehicles 2024-10-09 2025-12-31 16008940 core:FurnitureFittings 2024-10-09 2025-12-31 16008940 core:OfficeEquipment 2024-10-09 2025-12-31 16008940 dpl:AdministrativeExpenses 2024-10-09 2025-12-31 16008940 core:NetGoodwill 2024-10-09 2025-12-31 16008940 core:IntangibleAssetsOtherThanGoodwill 2024-10-09 2025-12-31 16008940 dpl:GroupUndertakings 2024-10-09 2025-12-31 16008940 dpl:ParticipatingInterests 2024-10-09 2025-12-31 16008940 dpl:GroupUndertakings core:ListedExchangeTraded 2024-10-09 2025-12-31 16008940 core:ListedExchangeTraded 2024-10-09 2025-12-31 16008940 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-10-09 2025-12-31 16008940 core:UnlistedNon-exchangeTraded 2024-10-09 2025-12-31 16008940 core:NetGoodwill 2026-05-05 16008940 core:IntangibleAssetsOtherThanGoodwill 2026-05-05 16008940 core:LandBuildings 2026-05-05 16008940 core:PlantMachinery 2026-05-05 16008940 core:Vehicles 2026-05-05 16008940 core:FurnitureFittings 2026-05-05 16008940 core:OfficeEquipment 2026-05-05 16008940 core:AfterOneYear 2026-05-05 16008940 core:WithinOneYear 2026-05-05 16008940 core:ListedExchangeTraded 2026-05-05 16008940 core:UnlistedNon-exchangeTraded 2026-05-05 16008940 core:ShareCapital 2026-05-05 16008940 core:SharePremium 2026-05-05 16008940 core:RevaluationReserve 2026-05-05 16008940 core:OtherReservesSubtotal 2026-05-05 16008940 core:RetainedEarningsAccumulatedLosses 2026-05-05 16008940 core:NetGoodwill 2025-12-31 16008940 core:IntangibleAssetsOtherThanGoodwill 2025-12-31 16008940 core:LandBuildings 2025-12-31 16008940 core:PlantMachinery 2025-12-31 16008940 core:Vehicles 2025-12-31 16008940 core:FurnitureFittings 2025-12-31 16008940 core:OfficeEquipment 2025-12-31 16008940 core:AfterOneYear 2025-12-31 16008940 core:WithinOneYear 2025-12-31 16008940 core:ListedExchangeTraded 2025-12-31 16008940 core:UnlistedNon-exchangeTraded 2025-12-31 16008940 core:ShareCapital 2025-12-31 16008940 core:SharePremium 2025-12-31 16008940 core:RevaluationReserve 2025-12-31 16008940 core:OtherReservesSubtotal 2025-12-31 16008940 core:RetainedEarningsAccumulatedLosses 2025-12-31 16008940 core:NetGoodwill 2024-10-08 16008940 core:IntangibleAssetsOtherThanGoodwill 2024-10-08 16008940 core:LandBuildings 2024-10-08 16008940 core:PlantMachinery 2024-10-08 16008940 core:Vehicles 2024-10-08 16008940 core:FurnitureFittings 2024-10-08 16008940 core:OfficeEquipment 2024-10-08 16008940 core:AfterOneYear 2024-10-08 16008940 core:WithinOneYear 2024-10-08 16008940 core:ListedExchangeTraded 2024-10-08 16008940 core:UnlistedNon-exchangeTraded 2024-10-08 16008940 core:ShareCapital 2024-10-08 16008940 core:SharePremium 2024-10-08 16008940 core:RevaluationReserve 2024-10-08 16008940 core:OtherReservesSubtotal 2024-10-08 16008940 core:RetainedEarningsAccumulatedLosses 2024-10-08 16008940 core:AfterOneYear 2026-01-01 2026-05-05 16008940 core:WithinOneYear 2026-01-01 2026-05-05 16008940 core:Non-currentFinancialInstruments core:CostValuation 2026-01-01 2026-05-05 16008940 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2026-01-01 2026-05-05 16008940 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2026-01-01 2026-05-05 16008940 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2026-01-01 2026-05-05 16008940 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2026-01-01 2026-05-05 16008940 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2026-01-01 2026-05-05 16008940 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2026-01-01 2026-05-05 16008940 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2026-01-01 2026-05-05 16008940 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2026-01-01 2026-05-05 16008940 core:Non-currentFinancialInstruments core:CostValuation 2026-05-05 16008940 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2026-05-05 16008940 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2026-05-05 16008940 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2026-05-05 16008940 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2026-05-05 16008940 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2026-05-05 16008940 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2026-05-05 16008940 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2026-05-05 16008940 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2026-05-05 16008940 core:Non-currentFinancialInstruments core:CostValuation 2025-12-31 16008940 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-12-31 16008940 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-12-31 16008940 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-12-31 16008940 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-12-31 16008940 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-12-31 16008940 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-12-31 16008940 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-12-31 16008940 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-12-31 16008940 bus:Director1 2026-01-01 2026-05-05 16008940 bus:Director2 2026-01-01 2026-05-05

ASTRIX HEALTH LIMITED

Registered Number
16008940
(England and Wales)

Unaudited Financial Statements for the Period ended
5 May 2026

ASTRIX HEALTH LIMITED
Company Information
for the period from 1 January 2026 to 5 May 2026

Directors | BLAKE, Thomas
| SWAMINATHAN, Abhinav

Registered Address | Arquen House
| 4-6 Spicer Street
| St. Albans
| AL3 4PQ

Registered Number | 16008940 (England and Wales)

ASTRIX HEALTH LIMITED
Balance Sheet as at
5 May 2026

| Notes | 05 May 2026 |  | 31 Dec 2025
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Current assets |  |  |  |  |  |  |  |
Debtors | 4 | - |  |  |  | 843 |  |
Cash at bank and on hand |  | 102 |  |  |  | 711 |  |
|  | 102 |  |  |  | 1,554 |  |
Creditors amounts falling due within one year | 5 | (109) |  |  |  | - |  |
Net current assets (liabilities) |  |  |  | (7) |  |  |  | 1,554
Total assets less current liabilities |  |  |  | (7) |  |  |  | 1,554
Creditors amounts falling due after one year | 6 |  |  | - |  |  |  | (9,330)
Net assets |  |  |  | (7) |  |  |  | (7,776)
Capital and reserves |  |  |  |  |  |  |  |
Profit and loss account |  |  |  | (7) |  |  |  | (7,776)
Shareholders' funds |  |  |  | (7) |  |  |  | (7,776)

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 3 July 2026, and are signed on its behalf by:
BLAKE, Thomas Director Registered Company No. 16008940

ASTRIX HEALTH LIMITED
Notes to the Financial Statements
for the period ended 5 May 2026

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Going concern
--- | ---
| During the period, the Directors resolved to apply for voluntary strike-off of the Company. The Company has ceased trading activities and intends to settle outstanding balances prior to dissolution. Consequently, the directors do not consider the going concern basis of accounting to be appropriate.These financial statements have therefore been prepared on a break-up basis. Assets have been stated at their estimated realisable values and liabilities at the amounts expected to be settled.

| Judgements and key sources of estimation uncertainty
--- | ---
| In preparing the financial statements on a break-up basis, the directors have exercised judgement in estimating the realisable value of assets and settled value of liabilities.

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Current taxation
--- | ---
| Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

2. | Average number of employees
--- | ---

|  | 2026 |  | 2025
| Average number of employees during the year | 0 |  | 1

3. | Further information regarding the company's income
--- | ---
| These financial statements have been prepared for the period from 1 January 2026 to 5 May 2026. This represents the Company's final set of financial statements before dissolution. The comparative figures represent the financial statements in the prior period covering 9 October 2024 to 31 December 2025.

4. | Debtors: amounts due within one year
--- | ---

|  | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £
| Other debtors | - |  | 843
| Total | - |  | 843

5. | Creditors: amounts due within one year
--- | ---

|  | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | 109 |  | -
| Total | 109 |  | -

6. | Creditors: amounts due after one year
--- | ---

|  | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £
| Amounts owed to related parties | - |  | 9,330
| Total | - |  | 9,330

7. | Related party transactions
--- | ---
| During the period, on 5 May 2026, the balance owed by the Company of £9,702 to its parent undertaking, Astrix Health Inc, based in the United States was waived in full. During the period, the Company provided software development services to its parent undertaking, Astrix Health Inc, based in the United States. Fees of £nil (2025: £61,521) were charged in accordance with the Group's transfer pricing policy and are considered to be at arm's length.